SOURCE: Equity News Circuit

Equity News Circuit

May 15, 2013 08:15 ET

Free Research Reports on CLX, FDS, SGEN and VAL Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwired - May 15, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

The Clorox Co. (NYSE: CLX) shares spiked over 2.2 percent Tuesday and have gained approximately 20 percent year-to-date. The company announced that it will raise its quarterly dividend from $0.64 per share to $0.71 per share, an increase of 11 percent. Clorox now offers investors a dividend yield of roughly 3.22 percent.

Find out more about Clorox including full access to the free equity report at: www.BedfordReport.com/CLX

FactSet Research Systems Inc. (NYSE: FDS) shares gained roughly 1.85 percent and have gained approximately 10.0 percent year-to-date. The company announced that its Board has approved a 13 percent increase to its quarterly dividend. FactSet now offers investors a quarterly dividend of $0.35 per share for a dividend yield of roughly 1.44 percent.

Find out more about FactSet including full access to the free equity report at: www.BedfordReport.com/FDS

Seattle Genetics, Inc. (NASDAQ: SGEN) shares gained roughly 3.3 percent Wednesday and are up approximately 66 percent year-to-date. The company announced that the FDA has accepted its application for its lymphatic cancer treatment, Adcetris, to be marketed for additional uses.

Find out more about Seattle Genetics including full access to the free equity report at: www.BedfordReport.com/SGEN

The Valspar Corporation (NYSE: VAL) shares surged 5.2 percent on volume of over 1.0 million shares traded Tuesday. The company reported earnings of $76.9 million, or $0.84 per share, for the fiscal second quarter, compared to earnings of $76.5 million, or $0.80 per share, in the year ago quarter.

Find out more about Valspar including full access to the free equity report at: www.BedfordReport.com/VAL

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information